Clinical trial
Clinical Control Study of Application of Nasal Stent and Merocel Sponge After Nasal Septoplasty
NCT05243147 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Control Study of Application of Nasal Stent and Merocel Sponge After Nasal Septoplasty
- Lead sponsor
- Peking University Third Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 22, 2020
- Completion date
- August 30, 2022
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nasal septum; deviation, congenital